Biosocieties

Papers
(The median citation count of Biosocieties is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Sexual health as surplus: the marketization of PrEP in Taiwan16
When sociality fails to produce solidarity: environmental NGOs and the politics of public engagement in contemporary China14
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time14
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria14
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests13
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation10
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies9
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis9
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence9
Making sense of snakebite: the place of biological toxins in social scientific analyses of toxicity7
Post-identifiability in changing sociotechnological genomic data environments6
Bleak Biopolitics and Abolitionist Aspirations: Recent Books on Race6
Challenges in public policy for the implementation of pharmacogenetic tests in Europe5
Epistemology of the side effect: anecdote and evidence in the digital age5
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities5
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs4
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices4
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar4
Openness in donor conception families4
Data roles: youth mental health outcome measures and the young people who defy them4
Psychedelic innovations and the crisis of psychopharmacology3
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building3
Allostatic load: historical origins, promises and costs of a recent biosocial approach3
Making death through producing life: Necrovalue and the political economy of death3
Value-creation in the health data domain: a typology of what health data help us do3
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016–20203
Our thanks to founding editor Professor Nikolas Rose3
Negotiating the necessity of biomedical animal use through relations with vulnerability3
Correction to: The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants3
It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’3
Population anxieties in constituting Nordic welfare state futures: affective biopolitics in the age of environmental crises2
Foetal programming meets human capital: biological plasticity, development, and the limits to the economization of life2
The normal is pathological: semi-conscious brains, mindless habits, and the paradoxical science of mindfulness2
Navigating biosafety concerns within COVID-19 do-it-yourself (DIY) science: an ethnographic and interview study2
Good donors, bad donors and oddities in the family tree: genomics, donation and reproductive citizenship in Finnish egg donor accounts2
Microbial eccentricity: more-than-human creativity in anthropoeccentric worlds2
Afterword: the politics of suspension as an analytical gestalt switch2
“Is your brain in danger of overheating?”: neurobiologizing the labouring subject in cognitive capitalism2
Correction: Reproducing the normal and the pathological in personalized cancer medicine clinical trials2
Diversity via datafication? Digital patient records and citizenship for sexuality and gender diverse people1
Anticipating and suspending: the chronopolitics of cryopreservation1
Inscrutable futures: biotechnology, architecture, and planetary ecology in late industrial China1
On psychedelic liberalism and mad trust: towards varieties of willing in extreme experiences1
Reproducing the normal and the pathological in personalized cancer medicine clinical trials1
The effects of COVID-19 on imagined reproductive futures1
Guardians of ableist family formation: the legitimation work of Danish abortion committees in cases of termination for fetal anomaly1
Correction: Core values of genomic citizen science: results from a qualitative interview study1
Forged in fires: notes on adaptive intelligence among Roma children in the "Terra dei Fuochi"1
Formatting patient knowledge and channelling participation: how patient organisations work under authoritarianism1
Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria1
More than sample providers: how genetic researchers in Pakistan mobilized a prenatal diagnostic service for thalassemia1
Chronic pain across clinical settings: the changing understanding of pain and its treatment in endometriosis1
The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants1
Making epistemic goods compatible: knowledge-making practices in a lifestyle intervention RCT on mindfulness and compassion meditation1
Antibiotics in the environment: molecularisation, drug resistance and pharmaceutical pollution in India1
Introduction to Special Issue: Reconceptualising toxicity and environmental justice1
‘Nonetheless biosocial’: experiences and embodied knowledge of birth cohort participants in the UK and Brazil1
Profit and power: negotiating medical authority and an informed consumer-patient in transgender surgery1
In whose pockets? How small Danish patient organisations balance legitimacy, representation and dependency in collaboration with public sector medical researchers and the life science industry1
‘Healthy’ for whom? ‘Healthy’ food’s effectivities, avocados, and the production of differentiated bodies1
‘Our biology is listening’: biomarkers as molecular vestiges of early life and the production of positive childhood experiences in behavioral epigenetics1
0.053534030914307